Fluphenazine and Hospitalisation - a phase IV clinical study of FDA data

Summary:

Hospitalisation is reported as a side effect among people who take Fluphenazine (fluphenazine decanoate), especially for people who are male, 60+ old, also take Risperdal Consta, and have Agitation.

The phase IV clinical study analyzes which people have Hospitalisation when taking Fluphenazine. It is created by eHealthMe based on reports of 2,335 people who have side effects when taking Fluphenazine from the FDA, and is updated regularly.

What is Fluphenazine?

Fluphenazine has active ingredients of fluphenazine decanoate. It is often used in schizophrenia. eHealthMe is studying from 2,364 Fluphenazine users. Check the latest studies of Fluphenazine.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,717 drugs and 1,133 conditions by eHealthMe. Check the latest studies of Hospitalisation.

On Jul, 20, 2026

2,335 people reported to have side effects when taking Fluphenazine.
Among them, 12 people (0.51%) have Hospitalisation.

Could Fluphenazine cause Hospitalisation?

Among these 12 people:

What is the gender of people who have Hospitalisation when taking Fluphenazine? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Hospitalisation when taking Fluphenazine? *

What are other drugs people take besides Fluphenazine? *

What are other side effects people have besides Hospitalisation? *

Weight Decreased: 1 person, 8.33%
Weakness: 1 person, 8.33%
Anal Haemorrhage: 1 person, 8.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 8.33%
Body Temperature Decreased: 1 person, 8.33%
Chills (felling of cold): 1 person, 8.33%
Diabetes: 1 person, 8.33%
Drug Ineffective: 1 person, 8.33%
Eye Injury: 1 person, 8.33%
Fatigue (feeling of tiredness): 1 person, 8.33%

What are the existing conditions these people have? *

Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 8.33%
Inappropriate Antidiuretic Hormone Secretion: 1 person, 8.33%
Ill-Defined Disorder: 1 person, 8.33%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 8.33%
Hepatitis C: 1 person, 8.33%
Drug Dependence: 1 person, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 1 person, 8.33%
Agitation (state of anxiety or nervous excitement): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Fluphenazine and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fluphenazine:

Fluphenazine (2,364 reports)

Hospitalisation treatments and more:

Hospitalisation (143,651 reports)

Browse all side effects of Fluphenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hospitalisation:

Hospitalisation (1,717 drugs)

Browse all the conditions that are associated with Hospitalisation:

Hospitalisation (1,133 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fluphenazine decanoate (the active ingredients of Fluphenazine) and Fluphenazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.